HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Tuschl Selected Research

Thomas Tuschl Research Topics

Disease

31Neoplasms (Cancer)
12/2023 - 09/2008
7Carcinogenesis
03/2013 - 09/2008
5Bites and Stings (Sting)
11/2023 - 08/2013
5COVID-19
11/2022 - 01/2021
4Breast Neoplasms (Breast Cancer)
12/2023 - 07/2011
4Fibrosis (Cirrhosis)
01/2022 - 12/2008
4Heart Failure
01/2021 - 12/2008
4Lupus Nephritis
01/2020 - 05/2017
4Infections
01/2017 - 04/2004
3Liposarcoma
01/2019 - 09/2011
3Neoplasm Metastasis (Metastasis)
10/2018 - 07/2011
3Virus Diseases (Viral Diseases)
01/2017 - 07/2009
2Inflammation (Inflammations)
01/2022 - 12/2015
2Carcinoma (Carcinomatosis)
09/2020 - 07/2011
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 04/2015
2Rhabdomyosarcoma
10/2016 - 08/2009
2Cardiovascular Diseases (Cardiovascular Disease)
09/2016 - 12/2008
2Cardiomegaly (Heart Hypertrophy)
02/2014 - 12/2008
2Inborn Genetic Diseases (Disease, Hereditary)
01/2014 - 03/2012
2Hepatocellular Carcinoma (Hepatoma)
09/2008 - 07/2007
1Hepatitis C
11/2022
1Liver Diseases (Liver Disease)
01/2022
1Skin Neoplasms (Skin Cancer)
01/2022
1Human Influenza (Influenza)
01/2022
1Pontocerebellar Hypoplasia
01/2021
1Cytokine Release Syndrome
01/2021
1Carcinoid Tumor (Carcinoid)
09/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2020
1Obesity
10/2019
1Hyperglycemia
10/2019
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019
1Adenocarcinoma of Lung
10/2018
1Hemangioma (Angioma)
01/2018
1Vascular Neoplasms (Neoplasms, Vascular)
01/2018
1Proteinuria
05/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Fatty Liver
09/2016
1Atherosclerotic Plaque (Atheroma)
09/2016

Drug/Important Bio-Agent (IBA)

37MicroRNAs (MicroRNA)IBA
01/2022 - 04/2005
18RNA (Ribonucleic Acid)IBA
12/2023 - 04/2004
12Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2011
10Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2007
6Antiviral Agents (Antivirals)IBA
11/2022 - 07/2007
5DNA (Deoxyribonucleic Acid)IBA
10/2022 - 06/2009
4NucleotidesIBA
01/2022 - 07/2011
4Small Cytoplasmic RNAIBA
01/2022 - 05/2017
4cyclic guanosine monophosphate-adenosine monophosphateIBA
11/2019 - 08/2013
3remdesivirIBA
11/2022 - 07/2021
3Messenger RNA (mRNA)IBA
01/2016 - 08/2009
3RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2014 - 11/2011
2InterferonsIBA
11/2023 - 08/2013
2Vaccine AdjuvantsIBA
11/2023 - 10/2022
2SofosbuvirIBA
11/2022 - 01/2021
2Exonucleases (3' 5' Exonuclease)IBA
01/2022 - 07/2021
2Viral RNAIBA
01/2022 - 07/2021
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 04/2015
2AntigensIBA
01/2015 - 01/2005
2LigandsIBA
10/2014 - 08/2013
2vadimezanIBA
09/2014 - 08/2013
2Phosphotransferases (Kinase)IBA
04/2014 - 12/2008
1Immunoconjugates (Immunoconjugate)IBA
12/2023
1Cyclic NucleotidesIBA
11/2023
1SugarsIBA
11/2023
1Arabinose (L-Arabinose)IBA
11/2023
12',3'-cyclic GMPIBA
11/2023
1Adenosine Monophosphate (AMP)IBA
11/2023
1Ribose (D-Ribose)IBA
11/2023
1Xylose (D-Xylose)FDA Link
11/2023
1grazoprevirIBA
11/2022
1NucleosidesIBA
11/2022
1elbasvirIBA
11/2022
1velpatasvirIBA
11/2022
1Subunit VaccinesIBA
10/2022
1Protein Subunit VaccinesIBA
10/2022
1Peptides (Polypeptides)IBA
10/2022
1ChromiumIBA
01/2022
1Ribonuclease P (RNase P)IBA
01/2022
1RNA Precursors (Precursor, mRNA)IBA
01/2021
1splicing endonucleaseIBA
01/2021
1daclatasvirIBA
01/2021
1Formaldehyde (Formol)FDA Link
12/2019
1CarbodiimidesIBA
12/2019
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1FructoseIBA
10/2019
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2019
1CateninsIBA
01/2019
1Smad3 ProteinIBA
10/2018
1Propranolol (Inderal)FDA LinkGeneric
01/2018
1AntioxidantsIBA
11/2017
1MethyltransferasesIBA
11/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1Methionine Sulfoxide ReductasesIBA
11/2017
1Immunoglobulin G (IgG)IBA
05/2017
1Viral DNAIBA
01/2017
1oxidized low density lipoproteinIBA
09/2016
1high density lipoprotein binding proteinIBA
09/2016

Therapy/Procedure

7Therapeutics
11/2023 - 03/2014
1Lasers (Laser)
12/2023
1Transplantation
01/2022